Concord Medical Services Holdings Limited
CCM
$4.30
-$0.01-0.23%
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Revenue | -24.08% | -27.10% | 85.92% | 82.98% | 0.74% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -24.08% | -27.10% | 85.92% | 82.98% | 0.74% |
Cost of Revenue | -26.58% | -29.50% | 30.25% | 28.20% | 0.05% |
Gross Profit | 39.44% | 41.84% | 60.24% | 60.87% | 3.36% |
SG&A Expenses | -4.31% | -8.12% | 6.12% | 4.44% | -9.77% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | -18.67% | -21.90% | 20.54% | 18.64% | -3.68% |
Operating Income | 12.32% | 15.80% | 17.86% | 19.15% | 8.39% |
Income Before Tax | 44.24% | 46.46% | 18.94% | 20.22% | -45.09% |
Income Tax Expenses | 98.14% | 98.22% | -128.11% | -124.52% | -4,364.56% |
Earnings from Continuing Operations | 37.73% | 40.21% | 24.37% | 25.56% | -29.91% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -14.87% | -18.26% | -23.73% | -24.94% | -30.20% |
Net Income | 45.76% | 47.92% | 25.19% | 26.37% | -86.30% |
EBIT | 12.32% | 15.80% | 17.86% | 19.15% | 8.39% |
EBITDA | 14.37% | 23.75% | 27.57% | 28.71% | 13.74% |
EPS Basic | 45.76% | 47.92% | 25.19% | 26.37% | 53.80% |
Normalized Basic EPS | -49.52% | -43.57% | -- | -- | -2.22% |
EPS Diluted | 45.71% | 47.87% | 25.19% | 26.37% | 53.72% |
Normalized Diluted EPS | -49.52% | -43.57% | -- | -- | -2.22% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |